NCT00093899View on ClinicalTrials.gov

A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

611

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

HyperlipidemiaHypercholesterolemiaHypertriglyceridemia

Interventions

DRUG

ezetimibe (+) simvastatin

Duration of Treatment: 6 months

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00093899 - A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) | Biotech Hunter | Biotech Hunter